• Title of article

    Dynein light chain 1, a p21-activated kinase 1-interacting substrate, promotes cancerous phenotypes

  • Author/Authors

    Vadlamudi، نويسنده , , Ratna K and Bagheri-Yarmand، نويسنده , , Rozita and Yang، نويسنده , , Zhibo and Balasenthil، نويسنده , , Seetharaman and Nguyen، نويسنده , , Diep and Sahin، نويسنده , , Aysegul A and den Hollander، نويسنده , , Petra and Kumar، نويسنده , , Rakesh، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2004
  • Pages
    11
  • From page
    575
  • To page
    585
  • Abstract
    We identified dynein light chain 1 (DLC1) as a physiologic substrate of p21-activated kinase 1 (Pak1). Pak1-DLC1 interaction plays an essential role in cell survival, which depends on Pak1ʹs phosphorylation of DLC1 on Ser88. Pak1 associates with the complex of DLC1 and BimL, a proapoptotic BH3-only protein, and phosphorylates both proteins. Phosphorylation of BimL by Pak1 prevents it from interacting with and inactivation of Bcl-2, an antiapoptotic protein. Overexpression of DLC1 but not DLC1-Ser88Ala mutant promotes cancerous properties of breast cancer cells. DLC1 protein level is elevated in more than 90% of human breast tumors. The regulation of cell survival functions by Pak1-DLC1 interaction represents a novel mechanism by which a signaling kinase might regulate the cancerous phenotypes.
  • Journal title
    Cancer Cell
  • Serial Year
    2004
  • Journal title
    Cancer Cell
  • Record number

    1335437